LT3200783T - Eritromelalgijos gydymas - Google Patents
Eritromelalgijos gydymasInfo
- Publication number
- LT3200783T LT3200783T LTEP15790622.3T LT15790622T LT3200783T LT 3200783 T LT3200783 T LT 3200783T LT 15790622 T LT15790622 T LT 15790622T LT 3200783 T LT3200783 T LT 3200783T
- Authority
- LT
- Lithuania
- Prior art keywords
- erythromelalgia
- treatment
- erythromelalgia treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1417497.3A GB201417497D0 (en) | 2014-10-03 | 2014-10-03 | Novel use |
| PCT/GB2015/052885 WO2016051194A1 (en) | 2014-10-03 | 2015-10-02 | Erythromelalgia treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3200783T true LT3200783T (lt) | 2019-09-10 |
Family
ID=51946794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP15790622.3T LT3200783T (lt) | 2014-10-03 | 2015-10-02 | Eritromelalgijos gydymas |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10231950B2 (lt) |
| EP (1) | EP3200783B1 (lt) |
| CY (1) | CY1122418T1 (lt) |
| DK (1) | DK3200783T3 (lt) |
| ES (1) | ES2751688T3 (lt) |
| GB (1) | GB201417497D0 (lt) |
| HR (1) | HRP20191434T1 (lt) |
| HU (1) | HUE047940T2 (lt) |
| LT (1) | LT3200783T (lt) |
| PL (1) | PL3200783T3 (lt) |
| PT (1) | PT3200783T (lt) |
| RS (1) | RS59479B1 (lt) |
| SI (1) | SI3200783T1 (lt) |
| WO (1) | WO2016051194A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| WO2018085521A2 (en) * | 2016-11-02 | 2018-05-11 | Biogen Inc. | Novel dosage regimen |
| BR112020021101A2 (pt) * | 2018-04-16 | 2021-02-23 | Biogen Ma Inc | métodos de tratamento da dor neuropática |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO870613L (no) | 1986-03-05 | 1987-09-07 | Molecular Diagnostics Inc | Deteksjon av mikroorganismer i en prve inneholdende nukleinsyre. |
| DE68928853T2 (de) | 1988-05-20 | 1999-08-05 | Cetus Corp | Befestigung von sequenzspezifischen proben |
| US5118801A (en) | 1988-09-30 | 1992-06-02 | The Public Health Research Institute | Nucleic acid process containing improved molecular switch |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| WO1993022456A1 (en) | 1992-04-27 | 1993-11-11 | Trustees Of Dartmouth College | Detection of gene sequences in biological fluids |
| US5474995A (en) | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5466823A (en) | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| WO1996025405A1 (en) | 1995-02-13 | 1996-08-22 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
| US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| UA57002C2 (uk) | 1995-10-13 | 2003-06-16 | Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. | Похідне (метилсульфоніл)феніл-2-(5н)-фуранону, фармацевтична композиція та спосіб лікування |
| TR199802049T2 (xx) | 1996-04-12 | 1999-01-18 | G.D.Searle & Co. | COX-2 Inhibit�rlerinin �nilac� olarak s�bstit�e edilmi� benzens�lfonamid t�revleri. |
| US5866336A (en) | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| US6117635A (en) | 1996-07-16 | 2000-09-12 | Intergen Company | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
| AU723179B2 (en) | 1996-07-18 | 2000-08-17 | Merck Canada Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| CO4960662A1 (es) | 1997-08-28 | 2000-09-25 | Novartis Ag | Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados |
| WO1999012930A1 (en) | 1997-09-05 | 1999-03-18 | Glaxo Group Limited | 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their prepa ration and their use as cyclooxygenase 2 (cox-2) inhibitors |
| BR9915011A (pt) | 1998-11-03 | 2001-08-07 | Glaxo Group Ltd | Compostos, método para a preparação dos mesmos, composição farmacêutica, métodos de tratamento de um indivìduo humano ou animal sofrendo de uma condição que é mediada pela inibição seletiva de cox-2 e sofrendo de um distúrbio inflamatório, e, uso de um composto |
| US6025683A (en) | 1998-12-23 | 2000-02-15 | Stryker Corporation | Motor control circuit for regulating a D.C. motor |
| JP2002538157A (ja) | 1999-02-27 | 2002-11-12 | グラクソ グループ リミテッド | ピラゾロピリジン |
| GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
| GB0021494D0 (en) | 2000-09-01 | 2000-10-18 | Glaxo Group Ltd | Chemical comkpounds |
| TW200730494A (en) | 2005-10-10 | 2007-08-16 | Glaxo Group Ltd | Novel compounds |
| BRPI0807972A2 (pt) * | 2007-01-24 | 2014-06-10 | Glaxo Group Ltd | Composições farmacêuticas compreendendo 3,5-diamino-6-(2,3-diclofenil)-l,2,4-triazina ou r(-)-2,4-diamino-5-(2,3-diclorofenil)-6-fluorometilpirim idina e uma nk1 |
| JP6251275B2 (ja) * | 2012-10-15 | 2017-12-20 | デウン ファーマシューティカル カンパニー リミテッド | ナトリウムチャンネル阻害剤、その製造方法およびその用途 |
| WO2014151393A2 (en) * | 2013-03-15 | 2014-09-25 | Purdue Pharma L.P. | Carboxamide derivatives and use thereof |
| GB201409851D0 (en) * | 2014-06-03 | 2014-07-16 | Convergence Pharmaceuticals | Diagnostic method |
| GB201417497D0 (en) * | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
| KR102412146B1 (ko) * | 2015-02-11 | 2022-06-22 | 주식회사 아이엔테라퓨틱스 | 소디움 채널 차단제 |
-
2014
- 2014-10-03 GB GBGB1417497.3A patent/GB201417497D0/en not_active Ceased
-
2015
- 2015-10-02 SI SI201530856T patent/SI3200783T1/sl unknown
- 2015-10-02 WO PCT/GB2015/052885 patent/WO2016051194A1/en active Application Filing
- 2015-10-02 HU HUE15790622A patent/HUE047940T2/hu unknown
- 2015-10-02 DK DK15790622.3T patent/DK3200783T3/da active
- 2015-10-02 PL PL15790622T patent/PL3200783T3/pl unknown
- 2015-10-02 RS RS20190994A patent/RS59479B1/sr unknown
- 2015-10-02 ES ES15790622T patent/ES2751688T3/es active Active
- 2015-10-02 US US15/516,031 patent/US10231950B2/en active Active
- 2015-10-02 LT LTEP15790622.3T patent/LT3200783T/lt unknown
- 2015-10-02 PT PT15790622T patent/PT3200783T/pt unknown
- 2015-10-02 EP EP15790622.3A patent/EP3200783B1/en active Active
-
2019
- 2019-01-22 US US16/254,251 patent/US20190388391A1/en not_active Abandoned
- 2019-08-08 HR HRP20191434TT patent/HRP20191434T1/hr unknown
- 2019-10-31 CY CY20191101134T patent/CY1122418T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3200783T3 (pl) | 2020-01-31 |
| WO2016051194A1 (en) | 2016-04-07 |
| HRP20191434T1 (hr) | 2020-10-02 |
| GB201417497D0 (en) | 2014-11-19 |
| US10231950B2 (en) | 2019-03-19 |
| HUE047940T2 (hu) | 2020-05-28 |
| EP3200783B1 (en) | 2019-07-31 |
| US20190388391A1 (en) | 2019-12-26 |
| ES2751688T3 (es) | 2020-04-01 |
| PT3200783T (pt) | 2019-08-21 |
| EP3200783A1 (en) | 2017-08-09 |
| CY1122418T1 (el) | 2021-01-27 |
| RS59479B1 (sr) | 2019-12-31 |
| DK3200783T3 (da) | 2019-08-05 |
| US20170304264A1 (en) | 2017-10-26 |
| SI3200783T1 (sl) | 2020-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL250387A0 (en) | combined treatment | |
| IL248856B (en) | New treatment | |
| GB201405033D0 (en) | Combination therapy | |
| GB201608885D0 (en) | Treatment | |
| GB201522243D0 (en) | Treatment | |
| GB201502137D0 (en) | Treatment | |
| ZA201702522B (en) | Combination therapy | |
| SG11201601030VA (en) | Massager | |
| GB201508841D0 (en) | Treatment | |
| GB201402179D0 (en) | Surface treatment | |
| LT3200783T (lt) | Eritromelalgijos gydymas | |
| ZA201608217B (en) | Combination therapy | |
| GB201411027D0 (en) | Treatment | |
| GB201503008D0 (en) | Treatment | |
| GB201617107D0 (en) | Treatment | |
| GB201612260D0 (en) | Treatment | |
| GB201612193D0 (en) | Treatment | |
| GB201609683D0 (en) | Treatment | |
| GB201518349D0 (en) | Treatment | |
| GB201515739D0 (en) | Treatment | |
| GB201514008D0 (en) | Treatment | |
| GB201413317D0 (en) | Atheroscierosis treatment | |
| GB201412410D0 (en) | Treatment | |
| GB201412411D0 (en) | Treatment | |
| GB201400235D0 (en) | Treatment |